European Stocks Subdued After Glum Novo Nordisk, Bayer Earnings

European stocks were muted on Wednesday following a slate of underwhelming results, including those from Bayer AG and Novo Nordisk A/S.

The Stoxx Europe 600 Index were little changed by the close after earlier gaining as much as 0.4%. Novo Nordisk fell 5.4% to the lowest since July 2021, with sales at the Danish drugmaker showing the weakest growth in four years.